Integrated Diagnostics Holdings plc
IDGXF
Get informed when a big investor buys or sells
+ FollowMarket Cap$307.84M
Close$
Share Statistics
| Market cap | $307.84 Million |
|---|---|
| Enterprise Value | $714.89 Million |
| Dividend Yield | $0.03 (4.85%) |
| Earnings per Share | $2.17 |
| Beta | 0.42 |
| Outstanding Shares | 581,326,272 |
Return
| Return on Equity | 38.51% |
|---|---|
| Return on Assets | 16.24% |
| Return on Invested Capital | 38.04% |
Valuation & Multiples
| P/E Ratio | 10.63 |
|---|---|
| PEG | 26.91 |
| Price to Sales | 0.04 |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 0.28 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 2.88 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$76.52 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$75.47 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Integrated Diagnostics Holdings plc
6,309 employees
CEO: Hend El Sherbini Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients. Its extensive service portfolio encomp...